α1-antitrypsin (AAT) Levels and Functions in Allogeneic Bone Marrow Transplantation and Throughout Progression Into GVHD

Clinical trial NCT03188601 · COMPLETED

Trial details

NCT number: NCT03188601
Sponsor: Rambam Health Care Campus
Status: COMPLETED
Study type: OBSERVATIONAL

GVHD Bone Marrow Transplant Failure Alpha 1-Antitrypsin

Start date: 2018-01-27
Primary completion: 2022-02-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.